This paper communicates the most relevant findings on renal cell carcinoma (RCC) presented at the 2006 annual meetings of the European Association of Urology (EAU), American Urological Association (AUA), and the American Society of Clinical Oncology (ASCO) and discussed during a closed meeting in Marbella in October 2006. Furthermore, the attendees’ opinions on a representative clinical case study were assessed using interactive voting and experts in the field commented on the results.
The most relevant new findings were selected by urologic experts in the field of RCC.
With regard to treatment of localised RCC, partial nephrectomy remains relatively uncommon, even for small tumours (<4
Relevant new data on surgical and minimally invasive treatment of localised disease and promising systemic treatments for advanced RCC were presented at the 2006 urologic/oncologic meetings.
Keywords: Angiogenesis inhibitors, Cryoablation, Partial nephrectomy, Radiofrequency ablation, Renal cell carcinoma, Sorafenib, Sunitinib, Temsirolimus.
Department of Urology, Università Vita Salute San Raffaele, Via Olgettina 60, 20132 Milan, Italy
Please visit www.eu-acme.org/europeanurology to read and answer questions on-line. The EU-ACME credits will then be attributed automatically.
© 2007 European Association of Urology, Published by Elsevier B.V.